Active Immunization of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) Using Fibroblasts Transfected With DNA From Autologous Tumor

Trial Profile

Active Immunization of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) Using Fibroblasts Transfected With DNA From Autologous Tumor

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 04 Feb 2016

At a glance

  • Drugs IC 1002 (Primary)
  • Indications Squamous cell cancer; Unspecified
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Jan 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Jul 2017, according to ClinicalTrials.gov record.
    • 14 Jan 2016 Planned initiation date changed from 1 Oct 2014 to 1 Apr 2015, according to ClinicalTrials.gov record.
    • 13 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top